Curasight AS (FRA:CUS) OCF Yield %: -7.19 (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CUS Curasight AS FRA:CUS
19 GF Score
Price €2.22
! 2 Warning Signs
View Full Analysis

What is Curasight AS OCF Yield %?

Curasight AS FRA:CUS -3.06% 19 OCF Yield % is -7.19 as of Aug. 03, 2026. GuruFocus rates FRA:CUS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 1,411 Biotechnology companies, Curasight AS ranks better than 53.86% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Curasight AS's Trailing 12-Month Cash Flow from Operations is €-8.76 Mil, and Market Cap is €110.85 Mil. Therefore, Curasight AS's OCF Yield % for today is -7.19%.

The historical rank and industry rank for Curasight AS's OCF Yield % or its related term are showing as below:

FRA:CUS' s OCF Yield % Range Over the Past 10 Years
Min: -7.19   Med: 0   Max: -7.19
Current: -7.19


During the past 8 years, the highest OCF Yield % of Curasight AS was -7.19%. The lowest was -7.19%. And the median was %.

FRA:CUS's OCF Yield % is ranked better than
53.86% of 1411 companies
in the Biotechnology industry
Industry Median: -8.79 vs FRA:CUS: -7.19

Curasight AS's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Curasight AS OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Curasight AS OCF Yield % Related Terms


Curasight AS OCF Yield % Historical Data

* Premium members only.

The historical data trend for Curasight AS's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curasight AS OCF Yield % Chart

Curasight AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -9.17

Curasight AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.68 -54.64 -32.84 -7.33 -11.49

FRA:CUS vs VRTX, REGN, RVMD: OCF Yield % Comparison

For the Biotechnology subindustry, Curasight AS's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curasight AS OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curasight AS's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Curasight AS's OCF Yield % falls into.


FRA:CUS
19GF Score
Curasight AS FRA:CUS
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curasight AS OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Curasight AS's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-6.924 / 75.478725
=-9.17%

Curasight AS's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-2.542 * 4 / 88.48416
=-11.49%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -7.19 mean?
Curasight AS (FRA:CUS) has a OCF Yield % of -7.19 as of Aug. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Curasight AS and its competitors. According to the industry distribution chart, Curasight AS ranks #651 out of 1411 companies in the Biotechnology industry, placing it in the top 46.1%.
Is Curasight AS's OCF Yield % too high?
Curasight AS's current OCF Yield % is -7.19. Based on the distribution chart, Curasight AS ranks #651 out of 1411 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Curasight AS has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curasight AS's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Curasight AS ranks #651 out of 1411 companies for OCF Yield %. This puts Curasight AS in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Curasight AS and its competitors. Curasight AS's current OCF Yield % is -7.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curasight AS stock overvalued right now?
Curasight AS (FRA:CUS) has a current OCF Yield % of -7.19. The current OCF Yield % is -7.19. Curasight AS's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Curasight AS (FRA:CUS), the current OCF Yield % is -7.19 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curasight AS Business Description

Other Exchanges CURAS:Sweden
Address Ole Maaloes Vej 3, Kobenhavn N, Kobenhavn, DNK, DK-2200
Curasight AS is a clinical-stage radiopharmaceutical company based in Copenhagen, Denmark, developing uTREAT, a first-in-class uPAR-targeted radioligand therapy (RLT) platform designed to treat aggressive solid tumors. The Company is focused on advancing its diagnostic and therapeutic platforms through key clinical milestones.
19GF Score

Get the complete analysis for FRA:CUS

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.22
Price